{"disease":{"id":"soluble-urokinase-plasminogen-activation-receptor","name":"soluble urokinase plasminogen activation receptor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05580016","title":"Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain.","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Poitiers University Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}